Dhipatimendi rePasi Pose

Munyika yose yekuongorora nekurapa kenza yemapapu, kuonekwa nekukurumidza uye kurapwa kwakarurama kwemapundu emapapu kwagara kuri chinhu chinonyanya kutariswa nevanorapa. Semimvuri yakakora mukufungidzira kwemapapu, mapundu emapapu akasiyana-siyana, kubva pakuzvimba kusina njodzi kusvika pakutanga...Verenga zvakawanda»

Murwendo rwekurwisa kenza, vezvehutano vanga vachitsvaga nzira dzekurapa dzinoshanda uye dzakachengeteka. Kunyange zvazvo kuvhiyiwa, radiotherapy, chemotherapy, uye biotherapy zvakaisa hwaro hwakasimba hwekurapa kenza, hyperthermia—tekinoroji yemazuva ano inobva muuchenjeri hwekare—...Verenga zvakawanda»

Kana wakatarisana nekuongororwa kwegomarara, tariro yakafanana yevarwere pasi rese ndeyekuwana nzira yekurapa inoshanda zvakanyanya, yepamusoro, uye isinganyanyi kukuvadza. Kana uchitsvaga chipatara chinosanganisa hunyanzvi hwepamusoro hwekurapa hwekuChina, tekinoroji yepamusoro, uye masevhisi epasi rose, ...Verenga zvakawanda»

Kana iwe kana mudiwa wako akaonekwa aine chirwere chegomarara uye uchinzwa usina simba kana kuti usina tariro paunenge uchitsvaga nzira dzekurapa munharaunda yako, unombozvibvunza here kuti: Kune rumwe rutivi rwenyika, kune nzira dzekurapa dzepamusoro-soro, dzisinganyanyi kupindira, uye dzine tariro dziripo here? Kuti uwane mibvunzo nezvekurapa kutsva kwegomarara...Verenga zvakawanda»

Murwere wegomarara remuuropi, uyo akadzoka kuchirwere mushure mekurapwa kweCAR-T ka17, akaona bundu rake richinyangarika zvachose mukati memavhiki mana mushure mekugamuchira mushonga mutsva weTIL uye akaramba asina bundu kwemwedzi inopfuura makumi maviri. Kana muchida kubvunza nezvekurapa kutsva kwegomarara nemiedzo yekiriniki: Nhare: 4008803716 | WeChat:...Verenga zvakawanda»

Musi wa17 Mbudzi, 2025, Abbisko yakazivisa kuratidzwa kweposita kwekushanda kwenguva refu, kuchengetedzeka uye mhedzisiro yakashumwa nevarwere kubva muongororo yepasi rose yePhase III MANEUVER yepimicotinib (ABSK021) muvarwere vane tenosynovial giant cell tumor (TGCT) paConnective Tissue Oncology Society (CTOS) 2025 ...Verenga zvakawanda»

Gunyana 8, 2025, InnoCare Pharma yakazivisa kuti HIBRUKA (orelabrutinib) yakatenderwa neHealth Sciences Authority (HSA) yeSingapore yekurapa varwere vakuru vane relapse or refractory marginal zone lymphoma (R/R MZL). Parizvino, kuchine miedzo yakawanda yekiriniki yechirwere chitsva...Verenga zvakawanda»

Musi wa28 Nyamavhuvhu, Center for Drug Evaluation (CDE) yeNational Medical Products Administration (NMPA) yakazivisa kuti BL-B01D1 yekubaiwa jekiseni inokurudzirwa kuti ibatanidzwe muongororo yekutanga. Yakagadzirirwa varwere vane chirwere chekenza chemumhino chinodzoka kana kuti chakapararira uye vane chirwere chegomarara remumhino...Verenga zvakawanda»

Musi wa21 Nyamavhuvhu, bispecific T cell engager, epcoritamab, yakapihwa mukana wekutarisa neCenter for Drug Evaluation (CDE) yeNational Medical Products Administration (NMPA). Kubvumidzwa uku kwakanangana nevarwere vakuru vane relapse or refractory follicular lymphoma (FL), iyo inonyanya kudiwa ...Verenga zvakawanda»

Nyamavhuvhu 29, mushonga weHERNEXEOS® (mapiritsi ezongertinib) waBoehringer Ingelheim wakatenderwa semushonga mumwe chete neNational Medical Products Administration (NMPA) yekurapa varwere vakuru vane kenza yemapapu isina kukuvadzwa, yakakwira munharaunda kana kuti inopararira isina masero madiki (NSCLC) ine mamota ane ...Verenga zvakawanda»

Musi wa22 Nyamavhuvhu, 2025, Datopotamab deruxtecan (Dato-DXd; Datroway) yakagamuchira mvumo muChina yekurapa varwere vakuru vane unresectable kana metastatic hormone receptor–positive, HER2-negative (immunohistochemistry [IHC] 0, IHC 1+, kana IHC 2+/in situ hybridization [ISH] negative) zamu...Verenga zvakawanda»

Muna Nyamavhuvhu 2025, Center for Drug Evaluation (CDE) yeNational Medical Products Administration (NMPA) yakapa zviri pamutemo Breakthrough Therapy Designation kuIna-cel, mushonga mutsva weCAR-T cell therapy unotungamirwa neCD19 wakagadzirwa neJuventas, wekurapa varwere vevana vane re...Verenga zvakawanda»